J. Goldman & Co LP - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 100 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 2.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2015$814,000
-76.6%
14,000
-83.0%
0.05%
-87.9%
Q4 2014$3,478,000
+21.2%
82,500
+11.5%
0.41%
+138.2%
Q3 2014$2,870,000
+91.0%
74,000
+53.8%
0.17%
+57.3%
Q2 2014$1,503,00048,1250.11%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2014
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders